susceptible to adverse event is_manufactured_by has vaccine component has vaccine antigen vaccinated in route immunizes host Catarrhini Homo sapiens Homo sapiens thrombosis with thrombocytopenia syndrome AE spike glycoprotein (SARS-CoV-2) intramuscular route Ad26.COV2.S Janssen vaccine PubMed:32731257 Ad26COVS1 JNJ-78436735 A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 vector expressing S protein. http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php Anthony Huffman, Philip Huang, Oliver He Johnson & Johnson COVID-19 vaccine vaccine adenovirus serotype 26 vaccine vector authorized COVID-19 recombinant adenoviral vector vaccine Janssen Pharmaceutica